IDEX CORP /DE/
Business
IDEX CORP /DE/ is a global applied solutions provider that designs, engineers and manufactures mission-critical components and systems for niche industrial, scientific, medical and safety markets. It offers pumps, valves, metering and flow-control systems, precision fluidics and optics, sealing solutions, pneumatic technologies, material processing equipment, firefighting and rescue apparatus, dispensing systems and stainless-steel banding and clamping products, along with related services. The company operates three reportable segments: Fluid & Metering Technologies, Health & Science Technologies and Fire & Safety/Diversified Products. Its products are sold worldwide through independent distributors, direct sales, OEM channels and service networks, with manufacturing and sales operations across the Americas, Europe, Asia and other regions.
Summary from filing dated 2025-02-20
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net sales | 3,458 | 3,269 | 3,274 | 3,182 | 2,765 | |
| Cost of sales | 1,919 | 1,824 | 1,827 | 1,755 | 1,540 | |
| Gross profit | 1,539 | 1,445 | 1,447 | 1,427 | 1,225 | |
| Selling, general and administrative expenses | 819 | 759 | 704 | 653 | 578 | |
| Restructuring expenses and asset impairments | 21 | 9 | 11 | 23 | 9 | |
| Operating income | 699 | 677 | 733 | 751 | 637 | |
| Gain on sale of businesses net | 0 | −4 | −85 | −35 | 0 | |
| Other expense (income) net | 2 | −3 | 5 | −4 | 16 | |
| Interest expense - net | 64 | 45 | 52 | 41 | — | |
| Income before income taxes | 633 | 639 | 760 | 749 | 580 | |
| Provision for income taxes | 150 | 135 | 165 | 163 | 131 | |
| Net income | 483 | 505 | 596 | 587 | 449 | |
| Net loss attributable to noncontrolling interest | 700,000 | 400,000 | 500,000 | 200,000 | 100,000 | |
| Net income attributable to IDEX | 483 | 505 | 596 | 587 | 449 | |
| Basic earnings per common share attributable to IDEX (in dollar per share) | 6.41 | 6.66 | 7.87 | 7.74 | 5.91 | |
| Diluted earnings per common share attributable to IDEX (in dollar per share) | 6.41 | 6.64 | 7.85 | 7.71 | 5.88 | |
| Basic weighted average common shares outstanding (in shares) | 75 | 76 | 76 | 76 | 76 | |
| Diluted weighted average common shares outstanding (in shares) | 75 | 76 | 76 | 76 | 76 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 580 | 621 | 534 | 430 | 855 | |
| Receivables net | 522 | 466 | 428 | 443 | 356 | |
| Inventories net | 479 | 430 | 421 | 471 | 370 | |
| Other current assets | 62 | 76 | 63 | 55 | 96 | |
| Total current assets | 1,643 | 1,593 | 1,446 | 1,399 | 1,678 | |
| Property, plant and equipment net | 468 | 460 | 430 | 382 | 327 | |
| Goodwill | 3,415 | 3,252 | 2,838 | 2,638 | 2,168 | |
| Intangible assets net | 1,247 | 1,285 | 1,012 | 948 | 597 | |
| Other noncurrent assets | 154 | 156 | 139 | 145 | 147 | |
| Total assets | 6,927 | 6,745 | 5,865 | 5,512 | 4,917 | |
| Trade accounts payable | 225 | 198 | 180 | 209 | 179 | |
| Accrued expenses | 297 | 279 | 272 | 289 | 260 | |
| Current portion of long-term borrowings | 700,000 | 101 | 600,000 | 0 | — | |
| Dividends payable | 53 | 53 | 49 | 46 | 41 | |
| Total current liabilities | 575 | 630 | 500 | 544 | 480 | |
| Long-term borrowings net | 1,820 | 1,860 | 1,325 | 1,469 | 1,190 | |
| Deferred income taxes | 303 | 267 | 292 | 264 | 196 | |
| Other noncurrent liabilities | 202 | 195 | 207 | 196 | 247 | |
| Total liabilities | 2,901 | 2,951 | 2,324 | 2,472 | 2,114 | |
| Commitments and contingencies (Note 10) | — | — | — | — | — | |
| Authorized: 5.0 million shares, $0.01 per share par value; Issued: None | 0 | 0 | 0 | 0 | 0 | |
| Authorized: 150.0 million shares, $0.01 per share par value Issued: 90.1 million shares at both December 31, 2025 and 2024 | 900,000 | 900,000 | 900,000 | 900,000 | 900,000 | |
| Treasury stock at cost: 15.5 million shares at December 31, 2025 and 14.2 million shares at December 31, 2024 | −1,423 | −1,170 | −1,187 | −1,184 | — | |
| Additional paid-in capital | 892 | 865 | 839 | 817 | 796 | |
| Retained earnings | 4,500 | 4,230 | 3,934 | 3,532 | 3,127 | |
| Accumulated other comprehensive income (loss) | 58 | −131 | −46 | −126 | −70 | |
| Total shareholders equity | 4,028 | 3,795 | 3,541 | 3,039 | 2,803 | |
| Noncontrolling interest | −1 | −600,000 | −200,000 | 300,000 | 0 | |
| Total equity | 4,026 | 3,794 | 3,541 | 3,040 | 2,803 | |
| Total liabilities and equity | 6,927 | 6,745 | 5,865 | 5,512 | 4,917 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Asset Impairments | 700,000 | 100,000 | 800,000 | 17 | — | |
| Credit loss on note receivable from collaborative partner | 0 | 0 | 8 | 0 | 0 | |
| Depreciation | 76 | 69 | 57 | 51 | 47 | |
| Amortization of intangible assets | 131 | 107 | 95 | 69 | 56 | |
| Share-based compensation expense | 27 | 26 | 22 | 22 | 20 | |
| Deferred income taxes | 13 | −19 | −15 | −19 | −6 | |
| Receivables net | −41 | −17 | 21 | −72 | −49 | |
| Inventories net | −34 | 18 | 66 | −72 | −46 | |
| Other current assets | 2 | −100,000 | −7 | −500,000 | 9 | |
| Trade accounts payable | 15 | 9 | −25 | 18 | 23 | |
| Deferred revenue | 3 | −18 | 13 | −25 | 20 | |
| Accrued expenses | 2 | −9 | −35 | 17 | 26 | |
| Other net | 5 | 2 | 5 | 700,000 | 4 | |
| Net cash flows provided by operating activities | 680 | 668 | 717 | 557 | 565 | |
| Capital expenditures | −64 | −65 | −90 | −68 | −73 | |
| Acquisition of businesses, net of cash acquired | −76 | −985 | −312 | −946 | −577 | |
| Proceeds from sale of businesses, net of cash remitted | 0 | 45 | 119 | 49 | 0 | |
| Purchase of marketable securities | 0 | 0 | −29 | 0 | −45 | |
| Proceeds from sale of marketable securities | 0 | 5 | 25 | 40 | 0 | |
| Other net | 2 | −7 | 4 | 7 | −3 | |
| Net cash flows used in investing activities | −138 | −1,007 | −284 | −917 | −698 | |
| Borrowings under revolving credit facilities | 252 | 279 | 0 | 210 | 0 | |
| Payments under revolving credit facilities | −323 | −69 | 0 | −135 | 0 | |
| Proceeds from issuance of long-term borrowings | 0 | 497 | 100 | 200 | 499 | |
| Payment of long-term borrowings | −100 | −50 | −250 | 0 | −350 | |
| Cash dividends paid to shareholders | −213 | −205 | −191 | −177 | −161 | |
| (Payments) proceeds from share issuances, net of shares withheld for taxes | −500,000 | 17 | 22 | — | — | |
| Repurchases of common stock | −248 | 0 | −24 | −148 | 0 | |
| Other net | −800,000 | −2 | −1 | −2 | −5 | |
| Net cash flows (used in) provided by financing activities | −633 | 466 | −345 | −38 | −10 | |
| Effect of exchange rate changes on cash and cash equivalents | 37 | −23 | 16 | −28 | −28 | |
| Net (decrease) increase in cash and cash equivalents and restricted cash | −53 | 105 | 104 | −425 | −171 | |
| Interest | 72 | 47 | 51 | 37 | 36 | |
| Income taxes - net | 135 | 171 | 200 | — | — |